tissu
obtain
postmortem
cattl
persist
infect
footandmouth
diseas
viru
fmdv
analyz
character
tissuespecif
local
fmdv
partial
transcriptom
profil
select
immunoregulatori
cytokin
analysi
distinct
anatom
site
steer
infect
fmdv
serotyp
highest
preval
overal
viral
detect
dorsal
nasopharynx
dorsal
soft
palat
fmdv
less
frequent
detect
laryng
mucos
tissu
oropharyng
mucos
site
lymph
node
drain
pharynx
immunomicroscopi
indic
within
persist
infect
mucos
tissu
fmdv
antigen
rare
detect
within
epitheli
cell
region
mucosaassoci
lymphoid
tissu
malt
transcriptom
analysi
persist
infect
pharyng
tissu
qrtpcr
cytokin
gene
indic
gener
trend
decreas
mrna
level
compar
uninfect
control
anim
although
statist
signific
differ
observ
greatest
suppress
rel
express
identifi
increas
rel
express
detect
overal
data
demonstr
fmdv
carrier
state
cattl
viral
persist
associ
epitheli
cell
nasopharynx
upper
respiratori
tract
decreas
level
mrna
sever
immunoregulatori
cytokin
infect
tissu
footandmouth
diseas
fmd
caus
fmd
viru
fmdv
member
aphthoviru
genu
picornavirida
famili
fmd
one
major
constraint
intern
trade
anim
product
due
extrem
contagi
broad
spectrum
host
speci
includ
wild
domest
rumin
suid
control
region
erad
fmdv
complic
exist
seven
serotyp
sever
subtyp
transmiss
air
occurr
prolong
asymptomat
carrier
state
larg
proport
infect
rumin
although
role
persist
infect
rumin
diseas
transmiss
remain
unclear
intern
standard
fmd
world
organ
anim
health
oie
indic
order
regain
fmdfree
statu
countri
must
demonstr
freedom
fmd
viru
infect
thu
asymptomat
fmdv
carrier
anim
perceiv
threat
exist
carrier
state
complic
regain
fmdfree
statu
basi
fmdfree
countri
gener
maintain
trade
barrier
anim
anim
product
countri
demonstr
absenc
fmdv
includ
absenc
carrier
anim
vanbekkum
et
al
first
document
presenc
infecti
fmdv
oropharyng
fluid
opf
asymptomat
cattl
sever
week
infect
later
confirm
sutmol
gaggero
fmdv
carrier
anim
subsequ
defin
anim
fmdv
recov
oropharyng
scrape
use
probang
sampl
cup
period
greater
day
post
infect
dpi
fmdv
persist
demonstr
occur
cattl
sheep
goat
asian
buffalo
variou
wildlif
speci
notabl
african
buffalo
persist
occur
variabl
incid
regardless
fmdv
vaccin
statu
clinic
outcom
infect
challeng
strain
dose
host
factor
includ
sex
age
review
salt
variou
mechan
propos
explain
inabl
anim
clear
viru
includ
variat
kinet
host
respons
fmdv
infect
viral
mutat
lead
antigen
variat
differ
innat
immun
respons
howev
mechan
respons
establish
mainten
resolut
carrier
state
remain
undetermin
variou
publish
work
implic
pharyng
tissu
cattl
predilect
site
fmdv
persist
similarli
sever
investig
confirm
collect
oropharyng
sputum
probang
devic
effect
manner
recoveri
fmdv
carrier
howev
techniqu
incap
indic
ident
specif
tissu
cell
within
viru
persist
burrow
first
perform
tissuespecif
isol
viru
fmdv
carrier
identifi
dorsal
soft
palat
ie
floor
nasopharynx
site
greatest
frequenc
viru
recoveri
highest
mean
infect
furthermor
cell
cultur
deriv
pharynx
persist
infect
cattl
shown
remain
fmdvposit
persist
also
establish
pharyng
primari
cell
cultur
uninfect
anim
fmdv
infect
ex
vivo
microscop
local
fmdv
rna
basal
layer
epithelium
dorsal
soft
palat
dsp
pharynx
demonstr
situ
hybrid
addit
fmdv
rna
antigen
detect
lymphoid
germin
center
pharyng
malt
tissu
lymph
node
cattl
day
challeng
without
concurr
detect
pharyng
epithelia
recent
studi
stenfeldt
et
al
describ
detect
low
level
fmdv
rna
biopsi
sampl
pharyng
epithelia
persist
phase
infect
lower
fmdv
rna
content
compar
probang
sampl
led
conclus
target
biopsi
area
within
dsp
consist
harbor
fmdv
replic
persist
infect
well
document
fmdv
subvert
earli
immun
respons
particularli
target
innat
immun
mechan
review
gold
et
al
occur
inhibitori
effect
cytokinedriven
pathway
result
impair
function
antigen
present
cell
precursor
review
grubman
et
al
ultim
could
lead
suboptim
immun
function
favor
viral
replic
delay
onset
specif
adapt
tcell
respons
interferon
ifn
type
ii
iii
demonstr
impair
fmdv
replic
vitro
vivo
order
success
replic
fmdv
block
express
ifn
ifnstimul
gene
isg
howev
vivo
replic
induc
synthesi
substanti
level
inf
iiii
cytokin
includ
shown
affect
fmdv
replic
dendrit
cell
dc
activ
matur
nk
cell
recruit
prolifer
activ
review
toka
et
al
addit
rant
also
associ
play
role
control
fmdv
replic
spread
publish
descript
regard
cytokin
involv
host
respons
carrier
stage
rel
express
level
baselin
without
statist
signific
describ
persist
infect
cattl
also
describ
might
effect
develop
persist
infect
vitro
vivo
addit
increas
level
mrna
describ
associ
fmdv
persist
cattl
howev
none
mechan
demonstr
repres
defin
event
establish
persist
infect
current
studi
investig
tissuespecif
local
fmdv
persist
infect
cattl
provid
detail
anatom
map
distribut
fmdv
persist
infect
tissu
addit
transcriptom
profil
select
immunoregulatori
cytokin
report
tissu
suggest
potenti
mechan
viral
persist
overal
conclus
nasopharyng
mucos
tissu
frequent
site
fmdv
persist
trend
suppress
cytokin
mrna
express
identifi
experiment
procedur
subject
prior
approv
plum
island
anim
diseas
center
institut
anim
care
use
committe
function
ensur
ethic
human
treatment
experiment
anim
includ
daili
monitor
health
experiment
anim
whenev
excess
pain
observ
step
taken
minim
anim
suffer
deliveri
analges
andor
antiinflammatori
drug
mg
per
kg
flunixin
meglumin
everi
h
andor
mgkg
butorphanol
tartrat
everi
h
pain
could
pharmacolog
control
anim
human
euthan
viru
inocul
steer
sedat
use
xylazin
im
mgkg
sedat
revers
tolazolin
iv
mgkg
euthanasia
perform
sedat
xylazin
util
fatalplu
iv
kg
experiment
subject
monthold
holstein
steer
weigh
kg
obtain
aaalac
associ
assess
accredit
laboratori
anim
care
intern
accredit
experimentallivestock
provid
thomasmorri
inc
reisterstown
md
experi
anim
hous
anim
facil
time
inocul
vaccin
time
euthanasia
steer
recruit
current
studi
primarili
serv
pathogenesi
vaccinationchalleng
studi
describ
herein
anim
infect
fmdv
strain
serotyp
without
previou
homolog
vaccin
group
challeng
perform
intradermolingu
contact
inocul
previous
describ
order
identifi
fmdv
carrier
convalesc
steer
screen
beyond
dpi
probang
sampl
follow
fmdv
rrtpcr
viru
isol
vi
fmdv
carrier
defin
steer
infecti
fmdv
recov
oropharyng
fluid
tissu
dpi
infecti
fmdv
defin
viru
abl
replic
cell
cultur
without
pretreat
sampl
triclorotrifluoroethan
tte
describ
probang
process
basi
definit
carrier
steer
select
investig
describ
tabl
experi
termin
predetermin
end
point
dpi
antemortem
sampl
consist
collect
sputum
sampl
use
probang
cup
describ
oie
terrestri
manual
chapter
section
b
briefli
approxim
ml
opf
collect
probang
cup
transfer
icecool
conic
tube
contain
ml
mem
hepe
opf
sampl
frozen
hour
process
see
necropsi
perform
immedi
subsequ
euthanasia
predetermin
timepoint
sampl
collect
scheme
predetermin
standard
minor
variat
among
individu
anim
maximum
anatom
distinct
tissu
collect
per
anim
tissu
specimen
collect
oral
caviti
nasal
caviti
soft
palat
pharynx
larynx
trachea
lung
lymph
node
skin
tabl
previous
describ
defin
specimen
two
mg
tissu
sampl
aliquot
separ
screwcap
ml
cryovial
frozen
immedi
liquid
nitrogen
transfer
within
h
freezer
store
time
process
adjac
specimen
tissu
place
cryomold
embed
optim
cut
temperatur
compound
oct
sakura
finetek
torranc
ca
frozen
bath
liquid
nitrogen
store
immunomicroscopi
antemortem
sampl
probang
rrtpcr
perform
describ
without
treatment
postmortem
sampl
tissu
two
specimen
tissu
list
tabl
thaw
immedi
macer
tissuelys
bead
beater
qiagen
valencia
ca
previous
describ
rna
extract
probang
sampl
macer
tissu
sampl
transfer
plate
thermo
scientif
waltham
contain
lysisbind
solut
rna
subsequ
extract
use
ambion
viral
rna
isol
kit
ambion
austin
tx
king
magnet
particl
processor
thermo
scientif
waltham
rna
elut
final
volum
extract
rna
analyz
rrtpcr
abi
system
appli
biosystem
austin
tx
previous
describ
sampl
cycl
threshold
ct
valu
consid
posit
rrtpcr
result
convert
fmdv
rna
copi
number
per
mg
tissu
previous
describ
ct
posit
cutoff
correspond
detect
threshold
valu
log
fmdv
rna
copiesmg
fmdv
rna
mg
tissu
realtim
rrtpcr
result
report
tabl
higher
fmdv
rnamg
valu
two
sampl
process
per
tissu
per
anim
tissu
obtain
postmortem
macer
describ
clear
bacteri
contamin
use
centrifug
tube
filter
spinx
costar
corn
ny
order
dissoci
virusantibodi
complex
therebi
improv
infecti
viru
detect
probang
fluid
sampl
treat
tte
purpos
ml
probang
ml
tte
homogen
ml
tube
use
tissu
lyser
describ
sampl
clarifi
centrifug
rpm
min
supernat
clear
bacteri
contamin
use
centrifug
tube
filter
spinx
costar
corn
ny
vi
perform
result
probang
test
k
rrt
previous
describ
separ
duplic
sampl
tissu
probang
sampl
lfbk
cell
express
bovin
integrin
upon
detect
cytopath
effect
cpe
fmdv
posit
confirm
rrtpcr
cell
cultur
supernat
sampl
cpe
observ
amplifi
three
blind
passag
supernat
test
rrtpcr
deem
neg
vi
result
tabl
report
posit
either
duplic
sampl
per
tissu
posit
tissuespecif
cumul
posit
percentag
pp
calcul
tissu
rrtpcr
vi
combin
rrtpcr
vi
pp
defin
total
posit
result
tissu
x
modal
persist
steer
total
specimen
tissu
x
examin
modal
persist
steer
thu
pp
serv
indic
preval
involv
tissu
persist
fmd
anim
within
test
modal
rrtpcr
vi
rrtpcr
vi
pp
valu
statist
compar
across
stratifi
variabl
tissu
categori
analysi
varianc
anova
commerci
avail
softwar
microsoft
excel
aliquot
mg
tissu
individu
lyse
ad
rlt
lysi
buffer
qiagen
valencia
ca
macer
use
rotorst
method
tissuem
fisher
scientif
approxim
homogen
transfer
qiagen
qiashredd
qiagen
total
rna
subsequ
isol
use
rneasi
kit
qiagen
recommend
manufactur
rna
concentr
determin
use
nanodrop
spectrophotomet
baselin
level
express
host
gene
interest
rant
establish
caudal
dsp
mockinocul
steer
n
rpcr
system
previous
describ
cdna
gener
rpcr
perform
describ
cdna
run
triplic
averag
individu
specimen
triplic
averag
steer
averag
gener
neg
control
baselin
ct
tissu
gene
interest
tissu
ie
caudal
dsp
fmdvinfect
steer
collect
process
analyz
express
gene
interest
describ
cytokin
gene
express
caudal
dsp
tissu
sampl
collect
fmdvcarrier
control
uninfect
anim
analyz
rel
gene
express
fmdvcarrier
control
normal
use
gapdh
housekeep
gene
statist
comparison
carrier
control
group
carri
random
data
point
group
calcul
rel
express
dct
gdph
formula
e
realtimepcr
assay
ck
refer
cytokin
evalu
cycl
differ
rna
detect
control
carrier
sampl
random
bootstrap
method
comput
statist
signific
confid
interv
calcul
use
rest
softwar
gener
random
pair
carrier
control
use
assay
effici
previous
determin
assay
laboratori
rel
express
ratio
cytokin
anim
comput
use
formula
ct
valu
individu
carrier
anim
mean
ct
valu
three
control
anim
anim
categor
two
group
base
rel
express
ratio
valu
regul
gene
express
associ
cytokin
express
vi
pcr
test
outcom
assess
use
chi
test
spss
softwar
use
comput
chi
valu
microscop
local
fmdv
antigen
host
protein
perform
cryosect
previous
describ
immunohistochemistri
detect
perform
micropolym
alkalin
phosphatas
kit
biocar
medic
multichannel
immunofluoresc
mif
detect
perform
goat
antimous
isotypespecif
secondari
antibodi
label
alexafluor
dye
mous
monoclon
antibodi
use
detect
protein
describ
previous
antibodi
use
label
cell
marker
mif
experi
mous
monoclon
antipancytokeratin
plu
biocar
antimhcii
abd
serotec
vmrd
clone
mif
experi
duplic
negativecontrol
serial
section
treat
isotypematch
irrelev
antibodi
isotyp
control
reagent
similar
concentr
includ
twenti
one
anim
fmdv
opf
tissu
dpi
therebi
met
requir
definit
fmdv
persist
tabl
select
anim
least
one
mani
probang
sampl
test
posit
fmdv
andor
fmdv
rna
fmdv
viral
rna
recov
opf
eighteen
steer
within
two
day
preced
euthanasia
due
logist
constraint
three
anim
euthan
later
four
day
five
day
posit
opf
sampl
tabl
probang
sampl
collect
select
carrier
anim
posit
rrtpcr
viru
isol
posit
rrtpcr
posit
vi
posit
techniqu
interestingli
amongst
anim
sever
probang
found
contain
infecti
fmdv
viral
rna
tissuespecif
cumul
percentag
posit
pp
calcul
detect
fmdv
rrtpcr
vi
combin
rrtpcr
vi
anim
span
three
viral
strain
fig
tabl
thu
pp
serv
indic
preval
involv
tissu
fmdv
persist
amongst
tissu
examin
nasopharynxlarynx
region
contain
site
highest
pp
infecti
fmdv
fmdv
rna
highest
pp
valu
detect
fmdv
rna
infecti
viru
combin
fmdv
detect
occur
rostral
dorsal
nasopharynx
tissu
next
highest
combin
pp
valu
caudal
dorsal
soft
palat
epiglotti
pp
valu
rrtpcr
vi
rrtpcr
vi
significantli
higher
categori
nasopharyngeallaryng
tissu
compar
tissu
p
within
nasopharyngeallaryng
tissu
mean
fmdv
rna
genom
copi
number
higher
amongst
nasopharyng
tissu
compar
tissu
larynx
howev
differ
statist
signific
neither
infecti
viru
fmdv
rna
ever
detect
tongu
dental
pad
nasal
septum
trachea
bronchial
bifurc
lung
parotid
hilar
lymph
node
esophagu
parotid
salivari
gland
skin
interdigit
cleft
coronari
band
metacarp
skin
fig
tabl
rel
mrna
express
number
cytokin
interest
measur
caudal
dsp
tissu
mean
compar
fmdvpersist
infect
steer
three
steer
comparison
test
null
hypothesi
fmdv
carrier
state
associ
alter
transcript
cytokin
gene
although
statist
signific
differ
cytokin
mrna
transcript
carrier
uninfect
control
anim
observ
gener
trend
reduct
express
tissu
carrier
compar
uninfect
control
cytokin
examin
fig
tabl
reflect
mean
express
ratio
weight
cytokin
specif
amongst
carrier
reduct
rant
cytokin
reduct
express
detect
chang
express
express
ratio
cytokin
show
increas
express
amongst
carrier
twofold
increas
rel
express
tissu
within
fmdv
fmdv
rna
detect
examin
convent
microscopi
immunohistochemistri
fig
mif
microscopi
fig
capsid
nonstructur
primari
antibodi
case
epithelia
consist
intact
evid
eros
ulcer
microvesicul
lymph
node
malt
popul
appropri
quantiti
cell
normal
tissu
architectur
fmdv
antigen
microscop
local
within
subset
analyz
tissu
within
nasopharyng
epithelia
fmdv
structur
nonstructur
protein
identifi
immunohistochemistri
scarc
individu
cell
small
cluster
immunoposit
cell
within
basal
andor
superfici
layer
epithelium
fig
epitheli
segment
contain
fmdv
antigen
typic
close
associ
malt
follicl
persist
fmdv
cattl
cytokin
express
often
line
open
lumen
crypt
addit
rare
singl
cell
contain
fmdv
protein
local
subepitheli
lymphoid
region
simultan
immunostain
host
cell
antigen
indic
fmdvposit
cell
morpholog
phenotyp
consist
epitheli
cell
cytokeratinmhcii
fig
tissu
cytokeratin
mhcii
intraepitheli
cell
presumpt
dc
close
proxim
never
observ
contain
fmdv
antigen
order
studi
virushost
interact
persist
fmd
cattl
carrier
steer
investig
tissuespecif
viru
distribut
host
respons
although
thoroughli
establish
carrier
cattl
shed
fmdv
opf
discrep
regard
precis
anatom
site
viru
persist
earlier
studi
report
epitheli
cell
pharyng
tissu
andor
retropharyng
submandibular
lymph
node
predilect
site
fmdv
persist
cattl
consensu
challeng
recent
studi
suggest
dsp
submandibular
retropharyng
lymph
node
definit
conclud
princip
site
persist
fmdv
due
inconsist
detect
fmdv
rna
tissu
extent
differ
across
studi
reflect
variat
experiment
design
util
differ
fmdv
strain
differ
treatment
inocul
well
differ
inocul
rout
remain
undetermin
current
studi
confirm
critic
consist
anatom
region
involv
persist
fmdv
infect
cattl
within
nasopharynx
larynx
accomplish
examin
distinct
tissu
per
anim
cattl
infect
one
three
serotyp
fmdv
specif
dorsal
nasopharynx
dorsal
soft
palat
epiglotti
greatest
proport
detect
fmdv
fmdv
rna
across
virus
interestingli
tissu
highest
preval
locat
tridimension
contigu
form
floor
roof
nasopharynx
anatom
region
within
waldey
ring
report
includ
primari
site
fmdv
infect
cattl
thu
pharyng
tissu
uniqu
structur
andor
function
properti
facilit
permiss
fmdv
infect
mainten
earli
persist
phase
fmd
fmdv
fmdv
rna
also
detect
within
ventral
soft
palat
ventral
larynx
region
lymph
node
retropharyng
submandibular
tonsil
palatin
nasopharyng
lower
preval
find
consist
previou
studi
suggest
tissu
also
may
involv
fmdv
persist
less
consist
pharyng
epithelia
malt
microscop
examin
numer
fmdvposit
nasopharyng
tissu
confirm
carrier
cattl
indic
histopatholog
lesion
present
anim
suggest
interact
viru
host
nasopharynx
carrier
state
quit
differ
occur
acut
infect
characterist
vesicl
feet
mouth
fmd
name
classic
microscop
lesion
consist
acantholyt
degener
keratinocyt
epitheli
spongiosi
slough
affect
region
result
eros
primari
infect
nasopharyng
epithelium
cattl
induc
less
sever
extent
appar
similar
process
result
keratinocyt
degener
ultim
cell
loss
eros
contrast
nasopharyng
epithelium
carrier
consist
found
intact
evid
eros
even
area
fmdv
antigen
local
lack
evid
cellular
degener
fmdvinfect
cell
carrier
suggest
distinct
mechan
infect
cell
surviv
remain
within
carrier
epithelium
find
consist
previous
publish
suggest
carrier
state
fmdv
employ
distinct
noncytolyt
infect
process
may
driven
alter
cytokin
signal
cascad
andor
tissu
specif
decreas
cell
death
mechan
fmdv
antigen
rare
microscop
local
tissu
macroscop
contain
fmdv
andor
fmdv
rna
region
antigen
found
local
foci
individu
small
cluster
immunoposit
cell
contrast
previou
report
demonstr
region
diffus
local
fmdv
rna
situ
hybrid
pharynx
carrier
cattl
reason
differ
local
unclear
may
support
concept
limit
viru
replic
cycl
carrier
wherebi
subset
fmdv
rnacontain
cell
progress
produc
viral
antigen
phenotyp
profil
intraepitheli
cell
contain
fmdv
antigen
uniformli
cytokeratin
mhcii
suggest
replic
fmdv
pharyng
epithelium
carrier
cattl
occur
epitheli
cell
rather
intraepitheli
dendrit
langerhanslik
cell
current
data
suggest
persist
phase
fmdv
infect
cattl
clear
lack
stimul
trend
toward
suppress
transcript
variou
host
cytokin
gene
site
viru
persist
recent
report
laboratori
describ
acut
phase
fmd
cattl
demonstr
modest
induct
cytokin
gene
tissu
tissuespecif
induct
ifn
signal
pathway
acut
phase
infect
fmdv
larg
similar
sever
viral
infect
gener
induc
proinflammatori
antivir
innat
immun
respons
contrast
exampl
wherein
persist
phase
fmdv
viral
infect
shown
associ
suppress
modul
host
immun
respons
thu
demonstr
rel
suppress
transcript
rant
similar
suppress
express
proinflammatori
cytokin
observ
herp
simplex
viru
type
persist
howev
conclus
report
immun
system
gene
suppress
publish
associ
fmdv
persist
infect
inde
two
studi
demonstr
upregul
tissu
cattl
persist
infect
fmdv
addit
decreas
detect
lower
ifn
signal
capac
demonstr
acut
phase
fmdv
infect
cattl
comparison
may
drawn
cytokin
modul
describ
herein
previou
account
describ
viral
infect
suppress
current
studi
previous
shown
inhibit
measl
viru
human
immunodefici
viru
hiv
therebi
demonstr
subvert
develop
cellmedi
immun
bovin
rotaviru
bovin
coronaviru
demonstr
downregul
ifn
proinflammatori
cytokineassoci
pathway
addit
persist
hepat
c
viru
infect
associ
disrupt
cellular
signal
pathway
lead
interferon
product
thu
block
antivir
activ
isg
evad
innat
immun
contribut
viru
persist
resist
therapi
establish
persist
fmdv
infect
provid
exampl
classic
pathogenesi
battl
pathogen
achiev
victori
defeat
host
immun
respons
howev
mechan
wherebi
fmdv
evad
host
respons
still
unclear
consid
current
transcriptom
data
context
previous
publish
work
allow
novel
insight
mechan
contribut
process
well
establish
fmdv
highli
sensit
ifn
type
ii
iii
sever
studi
document
ifn
product
cattl
part
acut
respons
fmdv
infect
thu
decreas
rel
express
mrna
pharyng
tissu
fmdv
carrier
describ
herein
suggest
associ
transcript
suppress
gene
fmdv
carrier
state
specif
find
suppress
mrna
express
amongst
carrier
suggest
immunomodul
may
benefit
persist
fmdv
suggest
investig
howev
causal
associ
remain
undermin
specif
one
might
consid
whether
fmdv
dysregul
express
gene
thu
enabl
carrier
state
subset
cattl
intrins
poor
produc
ifn
anim
ultim
becom
carrier
previou
work
describ
gene
express
tissu
differ
fmdv
tropism
noninfect
cattl
suggest
pharyng
tissu
intrins
poor
type
iii
ifn
induc
respond
might
explain
suscept
primari
persist
infect
zhu
et
al
result
current
studi
consist
find
manner
innat
cytokin
product
influenc
pathway
cellular
immun
add
anoth
level
mechanist
complex
consid
transcriptom
analysi
specif
current
studi
mrna
decreas
among
carrier
anim
induc
product
interferon
gammainduc
protein
togeth
involv
epiderm
dc
activ
matur
function
matur
dc
abl
produc
cytokin
involv
nk
cell
recruit
prolifer
activ
would
ultim
elimin
fmdv
infect
cell
review
toka
et
al
current
report
document
suppress
well
suppress
substanti
effect
persist
infect
tissu
carrier
thu
alter
region
cytokin
microenviron
may
preclud
cellular
pathway
requir
elimin
fmdv
infect
cell
current
work
contribut
defin
anatom
site
host
process
associ
persist
fmdv
cattl
trimod
detect
infecti
fmdv
fmdv
rna
viral
antigen
confirm
import
nasopharyng
mucos
surfac
site
fmdv
persist
although
wellestablish
fmdv
immunomodulatori
effect
variou
tissu
variou
stage
infect
precis
understand
process
remain
elus
comparison
cytokin
transcript
level
persist
infect
tissu
fmdvcarrier
cattl
compar
control
demonstr
gener
trend
suppress
transcript
gene
examin
includ
type
ii
ifn
variou
interleukin
although
effect
statist
signific
undeni
lack
immunostimul
often
expect
result
pathogen
infect
previous
report
fmdv
elucid
viral
modul
host
factor
associ
carrier
state
reveal
mechan
may
target
order
prevent
cure
fmdv
persist
effort
current
underway
laboratori
